Teladoc (TDOC) was one of the top beneficiaries of the COVID-19 pandemic. The telemedicine provider shot into the spotlight in 2020, as the market suddenly realized its growth potential. With patients ...

Last week, Citron Research made a splash after it labeled Teladoc Health (NYSE: TDOC) a hidden artificial intelligence (AI) opportunity that is still viewed by many as a "pandemic relic." Start Your ...

This company must be a fraud. This is a bold claim to make on national television in front of millions of people. But this is ...

Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7% ...

Photographer: Chris Ratcliffe/Bloomberg (Bloomberg) -- Citron Research suspended a scheduled live stream aimed at explaining its position on GameStop Corp. due to “too many people hacking Citron ...

Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company’s potential in a recent report.

Citron Research identified Teladoc as a potential AI opportunity hiding in plain sight. While Teladoc's revenue has plateaued, its profitability has grown. The stock is quite cheap compared to ...